B lymphocyte subset-based stratification in primary Sjögren's syndrome: implications for lymphoma risk and personalized treatment.

Journal: Clinical rheumatology
Published Date:

Abstract

OBJECTIVE: This study aimed to perform a detailed stratification analysis of B lymphocyte subsets in patients with primary Sjögren's syndrome (pSS) and to investigate their associations with lymphoma risk, clinical phenotypes, and disease activity.

Authors

  • Xuan Qi
    School of Petroleum Engineering, China University of Petroleum, Beijing 102249, China. 2017212184@student.cup.edu.cn.
  • Doudou Zhao
    Department of Rheumatology and Immunology, Peking University People's Hospital, Beijing, China.
  • Naidi Wang
    Department of Rheumatology and Immunology, Peking University People's Hospital, Beijing, China.
  • Yipeng Han
    Department of Rheumatology and Immunology, Peking University People's Hospital, Beijing, China.
  • Bo Huang
    Geriatrics Division, Department of Medicine, Peking University First Hospital, Beijing 100034, China.
  • Ruiling Feng
    Department of Rheumatology and Immunology, Peking University People's Hospital, Beijing, China.
  • Yuebo Jin
    Department of Rheumatology and Immunology, Peking University People's Hospital, Beijing, China.
  • Ruoyi Wang
    Department of Rheumatology and Immunology, Peking University People's Hospital, Beijing, China.
  • Xiang Lin
    Department of Computer Science, New Jersey Institute of Technology, Newark, NJ, USA.
  • Jing He
    School of Management, Guilin University of Aerospace Technology, Guilin, China.